Bill Status of HB 1335   99th General Assembly

Short Description:  RIGHT TO TRY ACT

House Sponsors
Rep. Gregory Harris-Daniel V. Beiser-David Harris-John D. Anthony-Esther Golar, Carol Ammons, Ann M. Williams, André Thapedi, Kelly M. Burke, Natalie A. Manley, David McSweeney, Cynthia Soto, Daniel J. Burke, Robert Martwick, Will Guzzardi, Elizabeth Hernandez, Edward J. Acevedo, John C. D'Amico and Kenneth Dunkin

Senate Sponsors
(Sen. Michael Connelly-Don Harmon-Linda Holmes)


Last Action  View All Actions

DateChamber Action
  8/5/2015HousePublic Act . . . . . . . . . 99-0270

Statutes Amended In Order of Appearance
New Act
225 ILCS 60/22from Ch. 111, par. 4400-22

Synopsis As Introduced
Creates the Right to Try Act. Provides that an eligible patient with a terminal illness who has considered all other treatment options approved by the United States Food and Drug Administration may acquire from a manufacturer an investigational drug, biological product, or device that has successfully completed Phase I of a clinical trial, but has not been approved for general use by the United States Food and Drug Administration. Provides that a manufacturer may, but is not required to, provide an investigational drug, biological product, or device to an eligible patient, either with or without receiving compensation. Provides that an accident and health insurer may, but is not required to, provide coverage for an eligible patient seeking such a drug, product, or device. Contains a penalty provision. Defines required terms. Contains legislative findings. Amends the Medical Practice Act of 1987. Provides that the Department of Financial and Professional Regulation may not revoke, suspend, place on probation, reprimand, refuse to issue or renew, or take any other disciplinary or non-disciplinary action against the license or permit of a physician to practice medicine based solely on the physician's recommendation to an eligible patient regarding, or prescription for, or treatment with an investigational drug, biological product, or device.

House Committee Amendment No. 1
Adds reference to:
210 ILCS 45/2-104from Ch. 111 1/2, par. 4152-104

Amends the Nursing Home Care Act. Provides that the requirements applicable to institutional review boards do not apply to investigational drugs, biological products, or devices used by a resident with a terminal illness as set forth in the Right to Try Act.

House Floor Amendment No. 2
Makes a technical change.

Actions 
DateChamber Action
  2/4/2015HouseFiled with the Clerk by Rep. Gregory Harris
  2/4/2015HouseFirst Reading
  2/4/2015HouseReferred to Rules Committee
  2/10/2015HouseAdded Chief Co-Sponsor Rep. John D. Anthony
  2/17/2015HouseAssigned to Judiciary - Civil Committee
  2/26/2015HouseAdded Chief Co-Sponsor Rep. David Harris
  2/26/2015HouseAdded Chief Co-Sponsor Rep. Esther Golar
  2/26/2015HouseChief Co-Sponsor Changed to Rep. David Harris
  2/26/2015HouseAdded Co-Sponsor Rep. Carol Ammons
  3/12/2015HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Gregory Harris
  3/12/2015HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/16/2015HouseHouse Committee Amendment No. 1 Rules Refers to Judiciary - Civil Committee
  3/18/2015HouseHouse Committee Amendment No. 1 Adopted in Judiciary - Civil Committee; by Voice Vote
  3/18/2015HouseDo Pass as Amended / Short Debate Judiciary - Civil Committee; 011-000-000
  3/18/2015HousePlaced on Calendar 2nd Reading - Short Debate
  3/18/2015HouseAdded Chief Co-Sponsor Rep. Daniel V. Beiser
  3/18/2015HouseAdded Co-Sponsor Rep. Ann M. Williams
  3/18/2015HouseAdded Co-Sponsor Rep. André Thapedi
  3/18/2015HouseAdded Co-Sponsor Rep. Kelly M. Burke
  3/25/2015HouseSecond Reading - Short Debate
  3/25/2015HousePlaced on Calendar Order of 3rd Reading - Short Debate
  4/10/2015HouseHouse Floor Amendment No. 2 Filed with Clerk by Rep. Gregory Harris
  4/10/2015HouseHouse Floor Amendment No. 2 Referred to Rules Committee
  4/14/2015HouseHouse Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 003-000-000
  4/14/2015HouseAdded Co-Sponsor Rep. Natalie A. Manley
  4/14/2015HouseAdded Co-Sponsor Rep. David McSweeney
  4/14/2015HouseRecalled to Second Reading - Short Debate
  4/14/2015HouseHouse Floor Amendment No. 2 Adopted
  4/14/2015HousePlaced on Calendar Order of 3rd Reading - Short Debate
  4/15/2015HouseThird Reading - Short Debate - Passed 114-001-001
  4/15/2015HouseAdded Co-Sponsor Rep. Cynthia Soto
  4/15/2015HouseAdded Co-Sponsor Rep. Daniel J. Burke
  4/15/2015HouseAdded Co-Sponsor Rep. Robert Martwick
  4/15/2015HouseAdded Co-Sponsor Rep. Will Guzzardi
  4/15/2015HouseAdded Co-Sponsor Rep. Elizabeth Hernandez
  4/15/2015HouseAdded Co-Sponsor Rep. Edward J. Acevedo
  4/15/2015HouseAdded Co-Sponsor Rep. John C. D'Amico
  4/15/2015HouseAdded Co-Sponsor Rep. Kenneth Dunkin
  4/15/2015SenateArrive in Senate
  4/15/2015SenatePlaced on Calendar Order of First Reading April 16, 2015
  4/15/2015SenateChief Senate Sponsor Sen. Michael Connelly
  4/16/2015SenateFirst Reading
  4/16/2015SenateReferred to Assignments
  4/22/2015SenateAdded as Alternate Chief Co-Sponsor Sen. Don Harmon
  4/22/2015SenateApproved for Consideration Assignments
  4/22/2015SenatePlaced on Calendar Order of 2nd Reading April 23, 2015
  5/12/2015SenateSecond Reading
  5/12/2015SenatePlaced on Calendar Order of 3rd Reading May 13, 2015
  5/19/2015SenateAdded as Alternate Chief Co-Sponsor Sen. Linda Holmes
  5/19/2015SenateThird Reading - Passed; 055-000-000
  5/19/2015HousePassed Both Houses
  6/17/2015HouseSent to the Governor
  8/5/2015HouseGovernor Approved
  8/5/2015HouseEffective Date January 1, 2016
  8/5/2015HousePublic Act . . . . . . . . . 99-0270

Back To Top